These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19565942)

  • 1. Steatohepatitis due to antiretroviral therapy.
    Gayle F; Lee MG; Hanchard B; Mills M
    West Indian Med J; 2008 Jan; 57(1):66-9. PubMed ID: 19565942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity of antiretrovirals: incidence, mechanisms and management.
    Núñez M
    J Hepatol; 2006; 44(1 Suppl):S132-9. PubMed ID: 16364487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic histopathology and clinical characteristics associated with antiretroviral therapy in HIV patients without viral hepatitis.
    Akhtar MA; Mathieson K; Arey B; Post J; Prevette R; Hillier A; Patel P; Ram LJ; Van Thiel DH; Nadir A
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1194-204. PubMed ID: 18989143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients.
    Labarga P; Soriano V; Vispo ME; Pinilla J; Martin-Carbonero L; Castellares C; Casado R; Maida I; Garcia-Gasco P; Barreiro P
    J Infect Dis; 2007 Sep; 196(5):670-6. PubMed ID: 17674307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatotoxicity of antiretroviral drugs in HIV HCV patients with congenital coagulopathies followed at an Haemophilia Unit during a decade.
    Sauleda S; Martorell M; Esteban JI; Tural C; Ruiz I; Puig L; Esteban R; Guardia J; Vargas V
    Haemophilia; 2006 May; 12(3):228-36. PubMed ID: 16643206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated liver enzymes in HIV monoinfected patients on HIV therapy: what are the implications?
    Ingiliz P; Benhamou Y
    J HIV Ther; 2009 Mar; 14(1):3-7. PubMed ID: 19731558
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of antiretroviral drug therapy in Jamaican children with HIV/AIDS.
    Pryce C; Pierre RB; Steel-Duncan J; Evans-Gilbert T; Palmer P; Moore J; Rodriguez B; Christie CD
    West Indian Med J; 2008 Jun; 57(3):238-45. PubMed ID: 19583122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.
    Aranzabal L; Casado JL; Moya J; Quereda C; Diz S; Moreno A; Moreno L; Antela A; Perez-Elias MJ; Dronda F; Marín A; Hernandez-Ranz F; Moreno A; Moreno S
    Clin Infect Dis; 2005 Feb; 40(4):588-93. PubMed ID: 15712082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity.
    Núñez M
    Hepatology; 2010 Sep; 52(3):1143-55. PubMed ID: 20812358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of incidence of zidovudine induced anemia in Indian human immunodeficiency virus positive patients in comparison with stavudine based highly active antiretroviral therapy.
    Rajesh R; Vidyasagar S; Varma DM; Mohiuddin S; Noorunnisa
    Int J Risk Saf Med; 2011; 23(3):171-80. PubMed ID: 22020397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV treatment-associated hepatitis.
    Orenstein R; LeGall-Salmon E
    AIDS Read; 1999 Aug; 9(5):339-46. PubMed ID: 12737123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive procedures to evaluate liver involvement in HIV-1 vertically infected children.
    Rubio A; Monpoux F; Huguon E; Truchi R; Triolo V; Rosenthal-Allieri MA; Deville A; Rosenthal E; Boutté P; Tran A
    J Pediatr Gastroenterol Nutr; 2009 Nov; 49(5):599-606. PubMed ID: 19668009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral drugs and liver injury.
    Soriano V; Puoti M; Garcia-Gascó P; Rockstroh JK; Benhamou Y; Barreiro P; McGovern B
    AIDS; 2008 Jan; 22(1):1-13. PubMed ID: 18090386
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.
    Torti C; Lapadula G; Casari S; Puoti M; Nelson M; Quiros-Roldan E; Bella D; Pastore G; Ladisa N; Minoli L; Sotgiu G; Mazzotta F; Lo Caputo S; Di Perri G; Filice G; Tinelli C; Carosi G;
    BMC Infect Dis; 2005 Jul; 5():58. PubMed ID: 16018804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection.
    Qurishi N; Kreuzberg C; Lüchters G; Effenberger W; Kupfer B; Sauerbruch T; Rockstroh JK; Spengler U
    Lancet; 2003 Nov; 362(9397):1708-13. PubMed ID: 14643119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatotoxicity of coinfected patients].
    Bessone F; Belloso W; Schroder T
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S43-5; discussion S74-82. PubMed ID: 16862858
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapine.
    Manfredi R; Calza L; Chiodo F
    HIV Clin Trials; 2005; 6(6):302-11. PubMed ID: 16452064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Looking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infection.
    Orenstein R; Tsogas N
    Pharmacotherapy; 2002 Nov; 22(11):1468-78. PubMed ID: 12432973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fatty liver and increased serum lactate in a woman with HIV].
    Lichterfeld M; Fischer HP; Spengler U; Rockstroh JK
    Dtsch Med Wochenschr; 2003 Jan; 128(3):81-4. PubMed ID: 12529837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
    Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
    Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.